A liposomal inverse vaccine protects mice from arthritis and experimental autoimmune encephalomyelitis
Journal of Controlled Release · 2026-11 · 399 · 115339
DOI: 10.1016/j.jconrel.2026.115339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Naomi Benne und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Immunology, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Ut…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Dexamethasone, Vaccines, Arthritis, Experimental. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation Flanders, Stichting ReumaNederland, Dutch Arthritis Association.
Abstract (Originalsprache)
Chronic autoinflammatory diseases such as rheumatoid arthritis and multiple sclerosis lack curative therapies, and current immunosuppressive treatments often cause systemic off-target effects. To address this unmet need, we previously developed an "inverse vaccine" based on anionic phosphatidylglycerol liposomes carrying a disease-specific peptide antigen conjugated to dexamethasone. Here, we assess the therapeutic efficacy and immunomodulatory mechanisms of this platform in two murine models of autoimmunity. In the proteoglycan-induced arthritis model, a single administration of liposomal dexamethasone-human proteoglycan peptide (Dex-K4-hPG) markedly slowed arthritis progression compared to an equivalent dose of free Dex-K4-hPG. Long-term follow-up showed that two injections provided superior protection over a single dose, whereas a third injection yielded no additional benefit. Flow cytometry of paw draining lymph nodes revealed reduced RORγt+CD4+ T cells in mice receiving multiple doses indicating a shift toward less pro-inflammatory T-cell responses. Histological staining of the knees of mice also revealed less damage to the joints of mice receiving 2 or 3 injections of liposomes. To evaluate the versatility of this platform, we generated a novel Dex-peptide conjugate by replacing hPG for myelin oligodendrocyte glycoprotein (MOG). The resulting Dex-K4-MOG conjugate was encapsulated in the liposomes at high encapsulation efficiency (∼60%), demonstrating platform modularity. In an experimental autoimmune encephalomyelitis mouse model, two injections of Dex-K4-MOG liposomes (one before disease induction and one after) strongly suppressed disease development compared with controls. Together, these findings demonstrate that antigen-specific inverse vaccination using anionic liposomes offers a modular and broadly applicable strategy for inducing long-term protection in multiple autoimmune disease models. The platform elicits regulatory immune signatures and suppresses pathogenic Th17 responses, supporting its potential as a tolerogenic therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Immunology, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Electronic address: n.benn…
- Section of Immunology, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
- Section of Immunology, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Utrecht Institute for Phar…
- Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium; University MS Center Hasselt, Pelt, Belgium.
- Utrecht Institute for Pharmaceutical Sciences, Department of Pharmaceutics, Faculty of Science, Utrecht University, Utrecht, the Netherlands.
- Section of Virology, Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Förderung
- Research Foundation Flanders
- Stichting ReumaNederland
- Dutch Arthritis Association
Zitieren
APA
Benne, N., Fernández, D. S., Porenta, D., Bolkaerts, L., Stoppelenburg, A. J., van den Dikkenberg, A., Kankipati, T. S., Mastrobattista, E., Hendriks, J. J. A., & Broere, F. (2026). A liposomal inverse vaccine protects mice from arthritis and experimental autoimmune encephalomyelitis. Journal of Controlled Release, 399, 115339. https://doi.org/10.1016/j.jconrel.2026.115339
Vancouver
Benne N, Fernández DS, Porenta D, Bolkaerts L, Stoppelenburg AJ, van den Dikkenberg A, et al. A liposomal inverse vaccine protects mice from arthritis and experimental autoimmune encephalomyelitis. Journal of Controlled Release. 2026;399:115339. doi:10.1016/j.jconrel.2026.115339
BibTeX
@article{Benne2026,
author = {Benne, Naomi and Fernández, Daniel Sáenz and Porenta, Deja and Bolkaerts, Laura and Stoppelenburg, Arie Jan and van den Dikkenberg, Antoinette and Kankipati, Teja Shyam and Mastrobattista, Enrico and Hendriks, Jerome J A and Broere, Femke},
title = {A liposomal inverse vaccine protects mice from arthritis and experimental autoimmune encephalomyelitis},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115339},
doi = {10.1016/j.jconrel.2026.115339}
}
EUVIMED